Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Beck-Popovic

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|December 17, 2005
A proposal for an international retinoblastoma staging systemGuillermo Chantada, François Doz, Celia B G Antoneli, et al.
Journal of Neuro-Oncology|July 18, 2012
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admissionFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Cancer Medicine|October 9, 2023
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studiesFabiën N Belle, Christina Schindera, Marc Ansari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN studyRuth Ladenstein, Dominique Valteau-Couanet, Penelope Brock, et al.
Pediatric Blood & Cancer|April 3, 2023
Optimising urinary catecholamine metabolite diagnostics for neuroblastomaYvette A H Matser, Iedan R N Verly, Maria van der Ham, et al.
Pediatric Blood & Cancer|July 18, 2018
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN studyDaniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, et al.
Frontiers in Pediatrics|October 27, 2022
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)Stefania Sorrentino, Shifra Ash, Riccardo Haupt, et al.
Progress in Retinal and Eye Research|June 8, 2019
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"Francis L Munier, Maja Beck-Popovic, Guillermo L Chantada, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2013
Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomesFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2021
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group StudyAlberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|December 17, 2005
A proposal for an international retinoblastoma staging systemGuillermo Chantada, François Doz, Celia B G Antoneli, et al.
Journal of Neuro-Oncology|July 18, 2012
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admissionFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Cancer Medicine|October 9, 2023
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studiesFabiën N Belle, Christina Schindera, Marc Ansari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN studyRuth Ladenstein, Dominique Valteau-Couanet, Penelope Brock, et al.
Pediatric Blood & Cancer|April 3, 2023
Optimising urinary catecholamine metabolite diagnostics for neuroblastomaYvette A H Matser, Iedan R N Verly, Maria van der Ham, et al.
Pediatric Blood & Cancer|July 18, 2018
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN studyDaniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, et al.
Frontiers in Pediatrics|October 27, 2022
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)Stefania Sorrentino, Shifra Ash, Riccardo Haupt, et al.
Progress in Retinal and Eye Research|June 8, 2019
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"Francis L Munier, Maja Beck-Popovic, Guillermo L Chantada, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2013
Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomesFirazia Rodjan, Pim de Graaf, Hervé J Brisse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2021
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group StudyAlberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, et al.
Pageof 10